Harry D Bear (Harry Bear)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Prostate Cancer

Top Venues

Cancer research

Journal of surgical oncology

Case reports in oncological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph F Mort, Shipra Maheshwari, Nayanika Basu, Patrick M Dillon, Kevin Brady, Harry D Bear, Trish Millard
A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim. Case reports in oncological medicine 2022 (2022)
Zheng Liu, Chunqing Guo, Swadesh K Das, Xiaofei Yu, Anjan K Pradhan, Xia Li, Yanxia Ning, Shixian Chen, Wenjie Liu, Jolene J Windle, Harry D Bear, Masoud H Manjili, Paul B Fisher, Xiang-Yang Wang
Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer research 81 (9) (2021)
Andrea J Luker, Laura J Graham, Timothy M Smith, Carmen Camarena, Matt P Zellner, Jamie-Jean S Gilmer, Sheela R Damle, Daniel H Conrad, Harry D Bear, Rebecca K Martin
The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC immunology 21 (1) (2020)
Harry D Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani, Richard L White, James Granfortuna, Judith O Hopkins, Dwight Oldham, Angel Rodriguez, Amy P Sing
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of surgical oncology 115 (8) (2017)